Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy
Conclusions Liver cirrhosis, high APRI levels, and IL28B rs12979860 at baseline are independent risk factors for HCC development in patients without SVR after peg-IFN combination therapy.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Cirrhosis | Diabetes | Diabetes Mellitus | Endocrinology | General Medicine | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Urology & Nephrology | Virology